Biosimilars Market Market Size The global biosimilars market is estimated to be worth USD 12.15 billion in 2024 and is anticipated to reach USD 148.23 billion by 2029 with a CAGR of 39.39% during the forecast period. Market Drivers The rising prevalence of chronic diseases and the cost-effectiveness of biosimilars compared to branded drugs are the major factors propelling the market growth...

Diagnostic Imaging Market Market Size The diagnostic imaging market size is estimated to be worth USD 40.9 billion in 2024 and is anticipated to reach USD 68.55 billion by 2032 with a CAGR of 6.67% during the forecast period. Market Drivers The rise in chronic diseases worldwide is enhancing the demand for the most efficient and accurate diagnosis equipment is the primary factor contributing...

Global Antibodies Market Market Size The global antibodies market size is estimated to be worth USD 183.7 billion in 2024 and is anticipated to reach USD 347.23 billion by 2029 with a CAGR of 11.31% during the forecast period. Market Drivers The growing prevalence of various chronic disorders and the escalating advancements in the healthcare industry is contributing to the increased demand...

ADHD Therapeutics Market Drivers: The rising prevalence of attention deficit hyperactivity disorders, even among children, is ascribed to bolstering the growth rate of the market. According to the National Institutes of Health, more than 5.3 million Children in the U.S. are suffering from ADHD. Also, it is affecting around 5-7.5% of young people which is a serious concern to get prominent...

Monoclonal Antibodies Market Drivers: The growing prominence of launching innovative treatment procedures, especially for targeted diseases, is attributed to leveraging the growth rate of the monoclonal antibodies market. In today’s world, people are more aware of seeking highly efficient treatment procedures at any cost, especially in developed countries. Chronic illnesses like diabetes,...

Market Size The medical cannabis market size is estimated to be worth USD 24.87 billion in 2024 and is anticipated to reach USD 69.75 billion by 2029 with a CAGR of 22.9% during the forecast period. Market Drivers The increasing awareness across the healthcare industry regarding the medicinal benefits of cannabis is the primary factor contributing to the market growth. The growing product...